106 Baines Ave, Hre


Reduce workload

Countries work on common applications (dossiers) which are submitted for registration. A manufacturer who submitted an application to at least two of the participating countries can request to have their products assessed jointly (via Zazibona)


ZAZIBONA is transitioning to a centralised process. Starting from the 12th February 2024, product applications must be submitted centrally using the online submission portal. Recommendations from the process can be used to support registrations at country level. More information is available from the Resources section.

previous arrow
next arrow

About Zazibona

ZAZIBONA is a collaborative medicines registration initiative in Southern Africa focusing on dossier assessments and good manufacturing practice (cGMP) inspections.

ZAZIBONA was founded in October 2013 by four countries Zambia, Zimbabwe, Botswana and Namibia with the support of WHO prequalification and the Southern Africa Regional Program on Access to Medicines (SARPAM).

Participating Countries

List of participating countries that make up Zazibona.


Non-Active (N)

Comoros Islands

Non-Active (N)


Non-Active (N)


Non-Active (N)


Non-Active (N)


Observer (O)


Observer (O)

Scope of Products

The ZaZiBoNa initiative assesses and evaluates a wide range of products, including essential medicines and medications used in the treatment of priority diseases or conditions identified by the Southern African Development Community (SADC).

The eligible products encompass the following SADC priority diseases or conditions:

Products included in the list of United Nations Commission for Life-Saving Commodities for Women and Children Final UN Commission Report_14sept2012.pdf ( are also eligible.

Upcoming Events